Skip to main content
Premium Trial:

Request an Annual Quote

Lumera Signs 10,000-Spot Protein Array Development Deal with Harvard Medical School

NEW YORK, Jan. 9 (GenomeWeb News) - Lumera has entered into a collaborative agreement with HarvardMedicalSchool and the Harvard Institute of Proteomics to develop protein microarrays, the company said today.

 

Lumera and HMS will develop a silicon chip substrate that combines Lumera's NanoCapture technology with HMS's NAPPA (nucleic acid programmable protein array) technology to create high-density protein arrays with 10,000 spots.

 

The 10,000-spot array "is a very important step towards our ultimate goal of producing a whole-proteome biochip," said Joshua LaBaer, director of the Harvard Institute of Proteomics, in a statement.

 

According to Lumera, current protein arrays are limited to around 800 spots.

 

The NAPPA technology, first published in the July 2004 issue of Science, starts with a printed cDNA array and generates a self-assembled protein array using a cell-free expression mix to produce proteins from the printed genes.

 

HMS and Lumera will share rights to jointly developed intellectual property. 

 

Further financial details were not disclosed.